However, it is important to recognize that several adverse events were more frequent in the lorundrostat group but did not reach statistical significance, likely due to limited power from including only three or fewer trials.
← all excerpts
Efficacy and safety of lorundrostat in uncontrolled hypertension: a meta-analysis.
1
—
—